HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare Fund (Direct, Growth): saplin Score 9.1/10 (Strong) among 14 Sectoral/Thematic funds. 3Y return 31.1% a year vs 21.9% category median, expense ratio 1.01%. Returns that beat most peers, with nothing standing out as a weakness. NAV ₹23.42 on 11 Nov 2026.
Loading the full analysis…